A previous study demonstrated that naringin effectively declined excessive weight gain of the liver alongside liver injury markers like AST and ALT, which denoted that naringin was repairing the damaged hepatic tissue as well as steatosis caused by HFD consumption [67]. The gene discussed is GPT; the disease is steatosis.